Abramson Cancer Center at Pennsylvania Hospital — Philadelphia, Pennsylvania

Abramson Cancer Center at Pennsylvania Hospital is a clinical research site located in Philadelphia, Pennsylvania, United States 19106.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Abramson Cancer Center at Pennsylvania Hospital has participated in 12 clinical trials with 3 currently active.

Therapeutic areas: Locally Advanced or Metastatic Solid Tumors, Kaposi Sarcoma, Skin.

Sponsors: Chugai Pharmaceutical, AIDS Malignancy Consortium, Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center at Pennsylvania Hospital?

Abramson Cancer Center at Pennsylvania Hospital has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center at Pennsylvania Hospital conducted?

Abramson Cancer Center at Pennsylvania Hospital has 12 clinical trials on record, with 3 currently active. Their work covers Locally Advanced or Metastatic Solid Tumors, Kaposi Sarcoma, Skin.

Is Abramson Cancer Center at Pennsylvania Hospital accredited by Crixeo Clinical Trials?

Abramson Cancer Center at Pennsylvania Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center at Pennsylvania Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.